Multi-scale effects of single-dose psilocybin in the macaque brain
This study utilizes multimodal imaging and multi-omics analyses in macaques to demonstrate that a single dose of psilocybin induces lasting functional network reorganization, enhanced energy metabolism, and neuroimmune modulation characterized by anti-inflammatory shifts and extracellular matrix remodeling in the primate brain.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
For centuries, humans have turned to certain natural substances to alter their state of mind, seeking relief from deep sadness or a new perspective on their lives. In recent years, a compound called psilocybin, found in some mushrooms, has shown remarkable promise in clinical trials for treating major depression. Doctors and researchers have observed that a single dose, when paired with psychological support, can lift the heavy fog of depression for weeks or even months. Yet, a crucial piece of the puzzle has remained missing. While we know the treatment works in people, we do not fully understand how it works inside the brain. The human brain is too complex and delicate to study at the level of individual cells and molecules while a person is alive. To bridge this gap, scientists have turned to our closest relatives, non-human primates, whose brains share a similar structure and organization with our own. By studying these animals, researchers can look at the brain from the inside out, connecting the large-scale changes seen in brain scans with the tiny chemical and cellular shifts happening at the same time.
A team of researchers recently took this approach to investigate what happens in the brain of a macaque monkey after a single dose of psilocybin. They wanted to see how the drug moves through the brain, changing its function and structure over time, from the first day after administration up to a week later. The study involved fifteen female macaques. Ten of them received a single injection of psilocybin, while five others served as a control group, receiving no drug. The scientists then watched the animals closely, tracking their sleep, their eating habits, and how they interacted with one another. They also used advanced magnetic resonance imaging to watch the brain's electrical activity and structure, collected fluid from around the spinal cord to analyze its chemical makeup, and finally, took small samples of brain tissue to read the genetic instructions inside individual cells.
The results revealed a story of change that unfolded in distinct stages. In the first few days after the dose, the monkeys' behavior shifted noticeably. They slept more deeply and spent less time awake or in light sleep. They also drank more water and ate more sweet food, though their preference for the sweet taste did not change, suggesting a general increase in appetite rather than a change in how they enjoyed food. Interestingly, their movement and social behavior remained largely the same a few days later, showing that the drug's effects were specific to certain parts of their daily lives rather than a general disruption of their routine.
When the researchers looked at the brain itself, they saw a sophisticated reorganization of how different regions talk to each other. The brain is divided into large networks that handle different tasks, such as planning, feeling emotions, or sensing the world. Before the drug, these networks operated with a certain level of separation. After the dose, the brain began to rewire itself. Within a day, the network responsible for complex thought and planning started to connect more strongly with the networks involved in memory and emotion. This connection stayed strong even a week later. At the same time, the brain became more segregated, meaning the different networks became more distinct from one another, which might help the brain process information more efficiently. These changes were not just electrical; the physical structure of the brain's wiring also showed signs of strengthening in specific pathways that link the front of the brain to the back and sides.
To understand the chemistry behind these changes, the scientists analyzed the fluid surrounding the brain and spinal cord. They found that the brain's environment went through a dramatic shift. In the first day, there was a surge of molecules associated with inflammation, a normal response to a new substance. But by the end of the week, this inflammatory signal had faded, replaced by a chemical environment rich in omega-3 fatty acids, which are known to support brain health and repair. The fluid also showed a sustained increase in enzymes that help the brain produce energy and manage stress, suggesting that the brain cells were working harder to fuel this new state of plasticity.
Digging deeper into the brain tissue itself, the researchers looked at the genetic activity of individual cells. They discovered that the drug had a very specific target: the deep layers of the brain's outer surface, particularly in the area responsible for decision-making and mood. In these deep layers, the cells that send signals to other parts of the brain turned up their production of a specific receptor that psilocybin binds to. These cells also increased their energy production, ramping up the machinery inside them that generates power. At the same time, the support cells in the brain, known as glia, changed their behavior. The immune-like cells in the brain shifted away from a state of alert and toward a state of repair, while the star-shaped support cells began to remodel the physical scaffolding around the neurons, making it easier for new connections to form.
The study suggests that the lasting benefits of psilocybin are not just a fleeting chemical high, but the result of a coordinated, multi-level response. The drug appears to trigger a chain reaction that starts with a specific receptor in deep brain cells, leading to a surge in energy use, a shift in the brain's immune environment from inflammation to repair, and a physical restructuring of how brain regions connect. This process seems to create a window of opportunity where the brain is more flexible and able to reorganize itself. While the study was conducted on healthy monkeys and not on patients with depression, it provides a detailed map of the biological events that follow a single dose. It shows that the brain does not just react to the drug; it actively remodels itself, building a new foundation for how it thinks and feels. This work offers a clearer picture of the biological machinery behind a treatment that is already helping people, pointing the way toward a deeper understanding of how the brain heals.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.